FDA
approval
· 2017-10-30
FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
Summary
FDA approved a supplemental application for a fixed-dose combination of amlodipine and atorvastatin, manufactured by Prasco Laboratories, enabling a generic ver…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)